Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patients
- 25 October 2007
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 299 (10) , 475-481
Abstract
Patients suffering from chronic mucocutaneous infections with the yeast Candida albicans (CMC) are discussed to have an underlying primary cellular immunodeficiency. In order to characterise cellular immunity in CMC patients, we analysed chemotaxis and myeloperoxidase (MPO) releases of neutrophils and T cell proliferation and cytokine production to Candida albicans. Patients with chronic mucocutaneous candidiasis (n = 4) and healthy volunteers of same sex and similar age (n = 14) were enrolled into the study. Neutrophil chemotaxis was assessed by transwell migration assay, and MPO release by ELISA. T cell proliferation capacity was investigated by thymidine incorporation and cytokine secretion in supernatants by ELISA. Neither neutrophil migration nor MPO release differed between CMC patients and healthy controls. The relative lymphocyte stimulation index (SI Candida/SI PHA) was heterogenous, but overall it was higher in CMC patients compared to controls. However, Candida-specific IFN-γ production was significantly reduced in CMC patients. Notably, Candida-specific T cell IL-10 production was markedly higher in CMC patients. The inability to clear the yeast Candida albicans in our CMC patients does not seem to be due to an impaired neutrophil function or reduced antigen specific proliferation of lymphocytes. In fact, our patients tended to proliferate stronger to Candida antigen relative to PHA than healthy controls. However, the impaired Th1 cytokine production with an enhanced IL-10 production could play an important role in the pathogenesis of chronic mucocutaneous Candida infections.Keywords
This publication has 30 references indexed in Scilit:
- Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndromeBritish Journal of Dermatology, 2006
- An Immune Defect Causing Dominant Chronic Mucocutaneous Candidiasis and Thyroid Disease Maps to Chromosome 2p in a Single FamilyThe American Journal of Human Genetics, 2001
- Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasisClinical and Experimental Immunology, 2001
- World Medical Association Declaration of HelsinkiJAMA, 1997
- Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis.Proceedings of the National Academy of Sciences, 1994
- Immunologic aspects of oral candidiasisOral Surgery, Oral Medicine, Oral Pathology, 1994
- Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.Journal of Clinical Investigation, 1994
- Lung disease assoclated with IgG subclass deficiency in chronic mucocutaneous candidiasisThe Journal of Pediatrics, 1991
- A Monocyte Disorder in Siblings With Chronic CandidiasisAmerican Journal of Diseases of Children, 1984
- Phagocytosis of Candida albicans in Chronic Mucocutaneous CandidiasisPediatric Research, 1981